News | June 02, 2025
Sanofi acquires US biopharma firm Blueprint Medicines for $9.1 billion
Adds fast-growing and only approved medicine for advanced and indolent systemic mastocytosis to the Sanofi portfolio
Adds fast-growing and only approved medicine for advanced and indolent systemic mastocytosis to the Sanofi portfolio
Ideal for extreme dry skin and hyperkeratotic conditions such as psoriasis and ichthyosis, Ureaderm offers the next step in evidence-based, effective skin hydration
For the full financial year FY25, revenue from operations grew 9 per cent to Rs. 11,537.8 crore, compared to Rs. 10,588 crore in FY24.
This significant milestone enhances our global regulatory standing
The transaction structured as share swap, is valued at ~Rs. 849 crore, with no cash outflow
Zydus MedTech gets rights to market the innovative Transcatheter Aortic Valve Implantation (TAVI) technology in India, Europe and other select markets
Being a premium partner for pharmaceutical companies by contributing to safety and productivity of pharmaceutical manufacture
GE HealthCare’s Revolution Vibe CT enables more facilities to elevate patient care by offering advanced cardiac imaging technology
This expanded partnership helps Evonik to streamline its distribution model in Asia Pacific
Havix was incorporated under the laws of the State of Delaware on February 17, 2015
Subscribe To Our Newsletter & Stay Updated
